Randox Liquid Cardiac Controls Catalogue Number CQ5052.

FDA Device Recall #Z-0413-2020 — Class II — October 4, 2019

Recall Summary

Recall Number Z-0413-2020
Classification Class II — Moderate risk
Date Initiated October 4, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Randox Laboratories, Limited
Location Crumlin, N/A
Product Type Devices
Quantity 7,505

Product Description

Randox Liquid Cardiac Controls Catalogue Number CQ5052.

Reason for Recall

Removal of claims for N-proBNP in the Liquid Cardiac Control catalogue number CQ5052 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots.

Distribution Pattern

US Distribution: WV, CA, DE, NJ, NY, GA, IN, PR OUS Distribution: CA, PL, CH, JP, NL, IT, CN, GB, IE, RU, MD, BY, SA, VN, AE, BH, DK, CO, ES, FR, TW, PH, TH, OM, HU, IN, KR, ZA, AU, CZ, PE, CL, IR, NZ, BE, DE, BA, SV, SK, HK, PT, PK, BR, TR, UA, SE, QA, LT, PE,

Lot / Code Information

Catalogue Number: CQ5052 GTIN: 05055273207453 Batch/lot: 4244CK (Exp. 28Nov2019), 4247CK (Exp. 28Nov2019), 4261CK (Exp. 28Nov2019), 4312CK Exp. 28Jun2020) and 4315CK (Exp. 28Jun2020)

Other Recalls from Randox Laboratories, Limited

Recall # Classification Product Date
Z-1017-2025 Class II Randox Lipoprotein (a) - In vitro diagnostic (... Dec 20, 2024
Z-1018-2025 Class II Randox Lipoprotein (a) - In vitro diagnostic (I... Dec 20, 2024
Z-1349-2020 Class II RX Daytona Plus (with ISE/without ISE); Models ... Dec 19, 2019
Z-0412-2020 Class II Randox Liquid Cardiac Controls Catalogue Number... Oct 4, 2019
Z-0414-2020 Class II Randox Liquid Cardiac Controls Catalogue Number... Oct 4, 2019

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.